유지혈액투석 환자에서 발생한 Nateglinide에 의한 지속 저혈당증 1예
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 노유석 | - |
dc.contributor.author | 이주학 | - |
dc.contributor.author | 김은영 | - |
dc.contributor.author | 신현종 | - |
dc.contributor.author | 박재일 | - |
dc.contributor.author | 한상웅 | - |
dc.contributor.author | 김호중 | - |
dc.date.accessioned | 2022-12-21T05:39:54Z | - |
dc.date.available | 2022-12-21T05:39:54Z | - |
dc.date.created | 2022-09-19 | - |
dc.date.issued | 2007-10 | - |
dc.identifier.issn | 2211-9132 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/179420 | - |
dc.description.abstract | The risk of development of hypoglycemia increases during glycemic control in end-stage renal disease (ESRD) patients. We report the case that an ESRD patient on maintenance hemodialysis has experienced sustained hypoglycemia with a nateglinide. A 73-year old male ESRD patient on hemodialysis was admitted with exertional dyspnea and increased liver function test. On the 4th day after admission, he had mental change with his blood glucose level of 41 mg/dL. His mental state improved promptly after intravenous injection of 25 g of glucose. To prevent rebound hypoglycemia 10% glucose solution was continuously infused and nateglinide was discarded. However, he has had recurrent hypoglycemic attacks until the 6th day after admission, and thereafter there was no further hypoglycemic attack. On the 5th day of admission, when there was second hypoglycemic attack, the fasting insulin level was 31.62 U/mL, indicating that hypoglycemia was accompanied by insulin hypersecretion. In conclusion, we suggest that nateglinide may provoke a severe and sustained hypoglycemia in an ESRD patient on maintenance hemodialysis and its use might be avoided. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한신장학회 | - |
dc.title | 유지혈액투석 환자에서 발생한 Nateglinide에 의한 지속 저혈당증 1예 | - |
dc.title.alternative | A Case of Sustained Hypoglycemia due to Nateglinide in a Maintenance Hemodialysis Patient | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 한상웅 | - |
dc.identifier.bibliographicCitation | Kidney Research and Clinical Practice, v.26, no.6, pp.797 - 800 | - |
dc.relation.isPartOf | Kidney Research and Clinical Practice | - |
dc.citation.title | Kidney Research and Clinical Practice | - |
dc.citation.volume | 26 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 797 | - |
dc.citation.endPage | 800 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001026930 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Hypoglycemia | - |
dc.subject.keywordAuthor | Nateglinide | - |
dc.subject.keywordAuthor | Hemodialysis | - |
dc.subject.keywordAuthor | End-stage renal disease. | - |
dc.subject.keywordAuthor | Hypoglycemia | - |
dc.subject.keywordAuthor | Nateglinide | - |
dc.subject.keywordAuthor | Hemodialysis | - |
dc.subject.keywordAuthor | End-stage renal disease. | - |
dc.identifier.url | https://www.krcp-ksn.org/journal/view.php?number=5397 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.